日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative infection risk in CAR T vs bispecific antibodies in B-cell lymphoma: a systematic review and meta-analysis

B细胞淋巴瘤中CAR-T疗法与双特异性抗体疗法的感染风险比较:系统评价和荟萃分析

van Besien, Herman; Easwar, Neela; Demetres, Michelle; Pasciolla, Michelle; Shore, Tsiporah; Leonard, John; Barker, Juliet; Martin, Peter; Yamshon, Samuel

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

套细胞淋巴瘤CAR-T细胞疗法后疾病进展的治疗及预后:一项多中心分析

Epstein-Peterson, Zachary D; Lionel, Anath C; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R; Chong, Elise A; Chong, Emeline R; Dela Cruz, Jamie; Frank, Matthew J; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A; Kamdar, Manali K; Karmali, Reem; Beyar-Katz, Ofrat; Maddocks, Kami J; Matasar, Matthew J; McLoughlin, Daniel; Merryman, Reid W; Munoz, Javier L; Navalekar, Rohini; Rhodes, Joanna; Riedell, Peter A; Ryan, Christine E; Salles, Gilles; Sauter, Craig S; Sawalha, Yazeed; Sharma, Samanvaya; Shouval, Roni; Shukla, Navika; Therwhanger, Dylan; van Besien, Herman; Varon, Ben; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes.

联合使用 EZH2 和 Bcl-2 抑制剂作为基因定义的 DLBCL 亚型的精准治疗

Scholze Hanna, Stephenson Regan E, Reynolds Raymond, Shah Shivem, Puri Rishi, Butler Scott D, Trujillo-Alonso Vicenta, Teater Matthew R, van Besien Herman, Gibbs-Curtis Destini, Ueno Hideki, Parvin Salma, Letai Anthony, Mathew Susan, Singh Ankur, Cesarman Ethel, Melnick Ari, Giulino-Roth Lisa